Volume 15, Number 3—March 2009
Research
Coccidioidal Pneumonia, Phoenix, Arizona, USA, 2000–2004
Table 1
No. patients | First serologic result |
Second serologic result |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
EIA IgM | EIA IgG | ID | CF | EIA IgM | EIA IgG | ID | CF | CF titer | ||
Negative serologic results: completed 2 tests | ||||||||||
11 | – | – | – | – | – | – | – | – | ||
5 | ND | ND | – | – | ND | ND | – | – | ||
3 | ND | ND | – | – | – | – | – | – | ||
6 | – | – | ND | ND | – | – | – | – | ||
1 | – | – | – | – | ND | ND | – | – | ||
1 | – | – | ND | ND | – | – | ND | ND | ||
1 | – | – | ND | ND | ND | ND | – | – | ||
1 |
– |
– |
– |
– |
– |
– |
ND |
ND |
||
Negative serologic results: completed 1 test | ||||||||||
10 | ND | ND | – | – | ND | ND | ND | ND | ||
4 | – | – | ND | ND | ND | ND | ND | ND | ||
6 |
– |
– |
– |
– |
ND |
ND |
ND |
ND |
||
Positive serologic results: completed 2 tests | ||||||||||
2 | – | – | – | – | + | – | + | – | ||
1 | ND | ND | – | – | + | – | + | + | 4 | |
1 | ND | ND | – | – | – | + | – | – | ||
1 | ND | ND | – | – | – | – | + | – | ||
1 |
– |
– |
– |
– |
– |
+ |
+ |
+ |
16 |
|
Positive serologic results: completed 1 test | ||||||||||
3 | + | – | – | – | ND | ND | ND | ND | ||
1 | ND | ND | ND | ND | – | – | – | + | 2 |
*EIA, enzyme immunoassay; Ig, immunoglobulin; ID, immunodiffusion; CF, complement fixation; ND, not done; –, negative test result; +, positive test result.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.